Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x100px
Document › Details

Oxford Nanopore Technologies plc. (9/10/24). "Press Release: Oxford Nanopore Seeks Discovery in Connection with Anticipated Breach of Contract Action".

Region Region United States (USA)
Organisation Organisation Oxford Nanopore Technologies plc (LSE: ONT)
  Group Oxford Nanopore (Group)
Products Product nanopore technology
  Product 2 nanopore DNA sequencer
     


Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore" or "the Group"), the company delivering a new generation of nanopore-based molecular sensing technology, today announces that it has filed an ex parte application under 28 U.S.C. § 1782 in the U.S. District Court for the Northern District of California, for leave to serve subpoenas on Complete Genomics, Inc., Innomics Inc. (formerly known as BGI Americas Corp.), MGI Americas, Inc. ("MGI"), and others in support of a lawsuit that Oxford Nanopore intends to file in the courts of England and Wales.

Oxford Nanopore anticipates bringing claims against BGI Tech Solutions Co., Ltd, BGI Group, BGI, Beijing Genomics Institute at Shenzhen, MGI Holdings Co., Limited and MGI Tech Co., Ltd in England for, inter alia, claims for breach of contractual obligations, claims for breach of common law obligations of confidence, breach of duties under the Trade Secrets (enforcement etc.) Regulations 2018, and an entitlement claim to a license of certain patents.  

Additionally, while not commenting on future litigation, the Group does not believe BGI's nanopore-based sequencing technology is able to be used in commercial products around the World without infringing or misappropriating the Group's substantial portfolio of proprietary rights.


-ENDS-


For further information, please contact:

Oxford Nanopore Technologies plc
Investors: ir@nanoporetech.com
Media: media@nanoporetech.com

Teneo (communications adviser to the Company)
Tom Murray, Olivia Peters
+44 (0) 20 7353 4200
OxfordNanoporeTechnologies@teneo.com


About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.

For more information please visit: www.nanoporetech.com

   
Record changed: 2024-09-26

Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Oxford Nanopore (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x300px




» top